T1	Premise 923 1011	Approximately one-half had hematologic toxicities and toxicity-related treatment delays.
T2	Premise 1012 1261	Approximately one-quarter had neurotoxicities and/or ototoxicites, moist desquamation, pneumonia, nausea and vomiting requiring hospitalization or intravenous fluids, dehydration or malnutrition requiring hospitalization, and mild or moderate fever.
T3	Premise 1262 1437	Although patients receiving the current intensity-modulated radiation therapy (IMRT) protocol using the Pinnacle(3) planning system had more toxicity-related treatment delays,
T4	Premise 1438 1680	they had fewer toxicities and better functional and health-related quality of life outcomes compared with those receiving conventional lateral opposing-field radiation or the initial IMRT protocol using the Best nomos PEACOCK planning system.
T5	Claim 1681 1884	Patients receiving CRT experience a substantial number of treatment-related adverse events, primarily affecting oropharyngeal and laryngeal function, with improvement noted for the current IMRT protocol.
R1	Support Arg1:T1 Arg2:T5	
R2	Support Arg1:T2 Arg2:T5	
R3	Support Arg1:T3 Arg2:T5	
R4	Support Arg1:T4 Arg2:T5	
